Subclinical Atrial Fibrillation
Conditions
Interventions
Intervention group:Further strengthening of long-term screening, management of risk factors, and anticoagulation and rhythm control therapy under specialist guidance
Control group:Patients in this group only received routine community management
Sponsors
Tianjin Medical University General Hospital
Eligibility
Sex/Gender
All
Age
65 Years to No maximum
Inclusion criteria
Inclusion criteria: Age>75 years, or age>65 years with a CHA2DS2-VASc score greater than 3
Exclusion criteria
Exclusion criteria: 1.Current or past diagnosis of atrial fibrillation, atrial flutter, or atrial tachycardia; 2.Currently receiving long-term anticoagulant therapy; 3.Receiving hospice care; 4.End-stage renal disease; 5.Diagnosed with moderate or more severe dementia; 6.Have an implanted pacemaker and/or defibrillator; 7.History of allergies (e.g., adhesive allergy to patches); 8.Known metastatic cancer.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Atrial fibrillation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Stroke/Transient Ischemic Attack (TIA);Anticoagulation therapy rate;All-cause mortality;Major adverse cardiovascular events;Major bleeding;New onset dementia; | — |
Countries
China
Contacts
Public ContactYang Qing
Tianjin Medical University General Hospital
Outcome results
None listed